Decoy Therapeutics (DCOY) Earnings Analysis

Decoy Therapeutics (DCOY) has no confirmed upcoming earnings date. Last quarter (2026-04-03) it missed with EPS -99.99 USD vs -6.48 USD est (-1443.1%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E -0.16.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does DCOY next report earnings?

No confirmed upcoming earnings date is currently scheduled for DCOY. This page updates as the calendar is published.

DCOY earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-03-99.99 USD-6.48 USD-1443.1%Miss
2025-11-14-1.81 USD-33.6 USD+94.6%Beat
2025-08-12-6.75 USD-33 USD+79.5%Beat
2025-03-21-9.9 USD-34.65 USD+71.4%Beat
2024-11-14-11.39 USD-2.4 USD-374.6%Miss
2024-08-09-35.53 USD-803.6 USD+95.6%Beat

Beat rate: 4/6 (67%) over reported quarters with consensus data.

DCOY valuation and analyst view

Trailing P/E-0.16
Trailing EPS-24.50067 USD
Price / book0.68
Dividend yield0.00%
Market cap0.00B
Analyst consensusBuy (1 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is Decoy Therapeutics (DCOY)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for DCOY. This page updates as the calendar is published.

Did DCOY beat earnings last quarter?

In its 2026-04-03 report, DCOY posted EPS of -99.99 USD versus a -6.48 USD estimate — a miss of 1443.1%.

What is DCOY's earnings track record?

Over the last 6 reported quarters with consensus data, DCOY beat estimates 4 times (67%).

What is DCOY's current P/E ratio and EPS?

DCOY trades at a trailing P/E of -0.16 on trailing EPS of -24.500674852622716 USD.

What do analysts rate DCOY?

Analyst consensus is "Buy" across 1 ratings (0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell).